<DOC>
	<DOCNO>NCT00210587</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness safety epoetin alfa ( PROCRITÂ® ) administer 80,000 Units every three week cancer patient receive chemotherapy radiation therapy .</brief_summary>
	<brief_title>An Efficacy Safety Study Epoetin Alfa ( PROCRIT ) Cancer Patients Not Receiving Chemotherapy Radiation</brief_title>
	<detailed_description>The current approved dosage epoetin alfa 40,000 Units per week escalation 60,000 Units per week response inadequate four week treatment 40,000 Units . This dose scheme , proven efficacious , often inconvenient patient medical personnel . This open-label , non-randomized , multi-center pilot study objective investigate efficacy epoetin alfa ( PROCRIT® ) regard hematopoietic response administer 80,000 Units subcutaneously every three week anemic patient cancer receive chemotherapy radiation therapy . Patients receive two epoetin alfa injection ( 40,000 Units per injection ) skin every three week maximum 13 week , total maximum four treatment . Doses may reduce depend patient ' hemoglobin level .</detailed_description>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Histologically confirm diagnosis nonmyeloid malignancy Baseline hemoglobin value &lt; = 11 g/dL unrelated transfusion Patients must receive plan receive chemotherapy radiotherapy within 13week study period . However , patient receive hormonal therapy nonmyelosuppressive therapy allowable Female patient reproductive potential must negative serum pregnancy test screening Patients must sign informed consent Uncontrolled hypertension History ( within 6 month ) uncontrolled cardiac arrhythmia , history pulmonary embolus , deep vein thrombosis , ischemic stroke , arterial venous thrombotic event ( exclude superficial thromboses ) , know history chronic coagulation disorder Transfusion within 28 day prior first dose Planned chemotherapy radiation study prior chemotherapy within 8 week radiation within 4 week study entry No prior treatment Epoetin alfa erythropoietic agent within previous two month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Anemia</keyword>
	<keyword>Neoplasms</keyword>
	<keyword>hemoglobin level</keyword>
</DOC>